APA (7th ed.) Citation

Juan Fita, M. J., Anido Herranz, U., Mendez-Vidal, M. J., Gironés-Sarrió, R., Muñoz-Langa, J., Sepúlveda-Sánchez, J., . . . Ángel Climent, M. (2023). Phase II Trial Evaluating Olaparib Maintenance in Patients with Metastatic Castration-Resistant Prostate Cancer Responsive or Stabilized on Docetaxel Treatment: SOGUG-IMANOL Study. Cancers, 15(21), 5223. https://doi.org/10.3390/cancers15215223

Chicago Style (17th ed.) Citation

Juan Fita, María José, et al. "Phase II Trial Evaluating Olaparib Maintenance in Patients with Metastatic Castration-Resistant Prostate Cancer Responsive or Stabilized on Docetaxel Treatment: SOGUG-IMANOL Study." Cancers 15, no. 21 (2023): 5223. https://doi.org/10.3390/cancers15215223.

MLA (9th ed.) Citation

Juan Fita, María José, et al. "Phase II Trial Evaluating Olaparib Maintenance in Patients with Metastatic Castration-Resistant Prostate Cancer Responsive or Stabilized on Docetaxel Treatment: SOGUG-IMANOL Study." Cancers, vol. 15, no. 21, 2023, p. 5223, https://doi.org/10.3390/cancers15215223.